The concentration and the structure of glycogen, and the activity of amylo-1,6-glucosidase have been determined in liver and muscle biopsies of 45 patients affected by type III glycogenosis. Amylo-1,6-glucosidase was measured by the formation of glucose from a phosphorylase limit dextrin (overall reaction), by the incorporation of [14C]glucose into glycogen, by the (1,4 → 1,4) transfer of an oligoglucan and by the hydrolysis of singly branched oligosaccharides. 34 cases were classified as type III A on the basis of a complete or nearly complete inactivity of the enzyme in the two tissues whatever the method used for its detection. 11 cases were characterized by an important residual activity of amylo-1,6-glucosidase which could be detected in the liver or in the muscle and by only some of the methods used.
No takes yet. Share an insight, caveat, or question.
Hoof et al. (1967) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: